More
    Guided Solutions - Connecting Talent With Innovation/div>

    FemDx Medsystems announces successful first-in-human study

    FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study. The procedure was performed in February 2025 and yielded highly...

    FemDx Medsystems announces successful first-in-human study

    FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study....

    HeartBeam and AccurKardia partner to advance cardiac monitoring innovation

    HeartBeam, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, announced a strategic collaboration with AccurKardia, an innovator in...

    Vivasure wins CE mark for bioresorbable PerQseal Elite device

    Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for percutaneous vessel closure. Vivasure’s device...

    LEM Surgical announces FDA clearance of Dynamis Robotic Surgical System

    LEM Surgical, a developer of advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    FemDx Medsystems announces successful first-in-human study

    FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study....

    Perfuze completes enrollment in stroke catheter study

    Perfuze announced it completed enrollment in its U.S. FDA investigational exemption (IDE) trial evaluating its stroke treatment. Galway, Ireland-based Perfuze also shared a new...

    Fire1 heart failure system performs well in first-in-human study

    Fire1 announced positive results from the first-in-human study of its novel, implantable heart failure (HF) management system. The FUTURE-HF study evaluated the safety and feasibility...

    Data backs Cala neurostim for treating essential tremor

    Cala announced new results from multiple clinical studies further expanding the body of evidence for its TAPS therapy. TAPS (transcutaneous afferent patterned stimulation) therapy...

    Innovation

    Regulatory Approvals

    FemDx Medsystems announces successful first-in-human study

    FemDx Medsystems, a pioneering medical device company focused on advancing gynecological diagnostics, is proud to announce the successful completion of its first-in-human clinical study....

    HeartBeam and AccurKardia partner to advance cardiac monitoring innovation

    HeartBeam, a medical technology company focused on transforming cardiac care by providing powerful personalized insights, announced a strategic collaboration with AccurKardia, an innovator in...

    Vivasure wins CE mark for bioresorbable PerQseal Elite device

    Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for percutaneous vessel closure. Vivasure’s device...

    LEM Surgical announces FDA clearance of Dynamis Robotic Surgical System

    LEM Surgical, a developer of advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted...

    M&A

    Archives

    Latest articles